C86.3 Subcutaneous panniculitis-like T-cell lymphoma

Name of the Condition

• Subcutaneous panniculitis-like T-cell lymphoma
• ICD-10 Code: C86.3

Summary

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare type of non-Hodgkin lymphoma that primarily affects the subcutaneous fat tissue, often presenting with skin lesions. It originates from T-cells and typically involves the lower extremities, trunk, or other areas with subcutaneous fat. The disease may progress locally or spread to other tissues if left untreated.

Causes

The exact cause involves genetic mutations in T-cells leading to uncontrolled proliferation. Immune system dysregulation and environmental factors may contribute to its development, though specific triggers are not fully established.

Risk Factors

• Immunosuppression (e.g., from medications or HIV)
• Female gender (more commonly reported)
• Young to middle-aged adults (most commonly reported in this age group)
• Prior exposure to certain immunomodulatory agents

Symptoms

• Painful or tender subcutaneous nodules or plaques
• Ulceration or necrosis of skin lesions
• Fever, night sweats, or unexplained weight loss
• Fatigue or weakness
• Systemic symptoms (e.g., cytopenias) in advanced cases

Diagnosis

Diagnosis involves a physical examination, followed by biopsy of affected subcutaneous tissue to confirm lymphoma type. Imaging (CT, PET) assesses disease extent, and blood tests evaluate cell counts and organ function. Flow cytometry and immunohistochemistry help identify T-cell markers and rule out other conditions.

Treatment Options

Treatment may include systemic chemotherapy, targeted therapy, or immunotherapy. Radiation therapy may be used for localized disease. Clinical trials or specialized protocols are often considered due to the rarity of the condition.

Prognosis and Follow-Up

Prognosis varies based on disease stage, response to treatment, and individual factors. Regular follow-up with imaging and blood tests monitors for recurrence or progression. Long-term surveillance is recommended due to the risk of relapse.

Complications

• Skin infection or ulceration
• Systemic symptoms (e.g., cytopenias)
• Disease progression to other tissues
• Treatment-related side effects (e.g., from chemotherapy)

Lifestyle & Prevention

No specific preventive measures are known. Maintaining overall health and avoiding unnecessary immunosuppression may reduce risk. Prompt evaluation of persistent skin lesions is advised.

When to Seek Professional Help

Seek medical attention for persistent, painful subcutaneous nodules, unexplained weight loss, fever, or skin ulceration. Early diagnosis improves outcomes.

Tips for Medical Coders

Document the anatomical site (e.g., subcutaneous tissue) and clinical findings (e.g., nodules, ulceration) to support code assignment. Ensure biopsy results confirm T-cell lymphoma and exclude other panniculitis or lymphoma types. Code C86.3 is specific to subcutaneous panniculitis-like T-cell lymphoma; do not use for other T-cell lymphomas.